Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

23847studies shown

Showing 9,541-9,552 of 23,847

CompletedNCT01514682

Anti-Inflammatory Treatment of Schizophrenia

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Baltimore

SchizophreniaBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

View study

CompletedEUCTR 2013-000389-12

ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Placebo Controlled study

This study is completed in the United Kingdom. It focuses on Schizophrenia.

In United Kingdom

SchizophreniaOther

Countries: United Kingdom
Sponsor: Cardiff University
Condition: Schizophrenia

View study

WithdrawnNCT01272752

Anti-psychotic Medication (New Use) Weight Loss Study

This summary needs review. Please check the official study record and contact the research team for details.

In Sioux Falls

SchizophreniaOtherOver 18 Years

Countries: United States
Sponsor: Avera McKennan Hospital & University Health Center
Condition: Schizophrenia

View study

WithdrawnNCT01272765

Anti-psychotic Medication (Stable Dose) Weight Loss Study

This summary needs review. Please check the official study record and contact the research team for details.

In Sioux Falls

SchizophreniaOtherOver 18 Years

Countries: United States
Sponsor: Avera McKennan Hospital & University Health Center
Condition: Schizophrenia

View study

TerminatedNCT04480554

Anti-retroviral Therapy, Medications for Addiction, Opioids and HIV Infection - Study 1

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Philadelphia

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States, Vietnam
Sponsor: University of Pennsylvania
Condition: Addiction

View study

WithdrawnNCT04234516

Anti-suicidal Effects of Buprenorphine in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In New York

Addiction, SuicidalityBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction, Suicidality

View study

WithdrawnNCT05427981

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

This summary needs review. Please check the official study record and contact the research team for details.

In New York

Depression, SuicidalityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Depression, Suicidality

View study

CompletedNCT01617083

Antibiotic Treatment study for the PANDAS/PANS Phenotype

This summary needs review. Please check the official study record and contact the research team for details.

In St. Petersburg

OCDDrugFrom 4 Years to 14 Years

Countries: United States
Sponsor: University of South Florida
Condition: OCD

View study

CompletedNCT00550576

Antibodies to Digoxin for Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Haifa

BipolarityDrugFrom 20 Years to 65 Years

Countries: Israel
Sponsor: Rambam Health Care Campus
Condition: Bipolarity

View study

TerminatedNCT00715377

Anticholinergic Burden in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

SchizophreniaDrugOver 50 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

View study

CompletedNCT00288366

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In Nashville

Schizophrenia, BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Northwestern University
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00169988

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks

SchizophreniaDrugFrom 12 Years to 22 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.